|

mFOLFOXIRI plus Bevacizumab Clinical Trials

2 actively recruiting trials

Also known as: 5-Fluorouracil, Bevacizumab, Irinotecan, Leucovorin, Oxaliplatin

Pipeline

Phase 3: 2

Top Sponsors

  • Yanhong Deng1
  • Fudan University1

Indications

  • Colorectal Cancer2
  • Cancer2
  • Liver Disease1
  • Liver Metastases1
  • Liver Cancer1

Other2 trials

Bevacizumab Plus mFOLFOXIRI as First-line Treatment for Patients With Unresectable Metastatic Colorectal Cancer
Phase 3
Conversion Therapy of RAS/BRAF Wild-Type Colorectal Cancer Patients With Initially Unresectable Liver Metastases
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.